Instil Bio (TIL) IPO Opens 35% Higher

Today's IPO for Instil Bio, Inc. (NASDAQ: TIL) opened for trading at $27 after pricing 16,000,000 shares of common stock at a price to the public of $20.00 per share.

Morgan Stanley, Jefferies and Cowen are acting as joint book-running managers for the offering. Truist Securities is acting as lead manager for the offering.

Instil Bio is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer.

You May Also Be Interested In

• SpaceX prices IPO at $135 per share for June 12 Nasdaq debut
• SpaceX IPO over four times oversubscribed - Bloomberg
• TD Cowen Starts NervGen Pharma Corp (NGEN) at Buy, 'A New Generation In Spinal Cord Injury Treatment Is Here'